Jannie Borst

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Indu Khatri

Leiden University Medical Center

NETHERLANDS

View details

Abhishek Garg

Professor at KU Leuven

KU Leuven

BELGIUM

View details

Elisa Matas-Rico

Lecture Professor

University of Malaga

SPAIN

View details

Stefan Naulaerts

Katholieke Universiteit Leuven

BELGIUM

View details

Sandra Tuyaerts

Vrije Universiteit Brussel

BELGIUM

View details

Mirjam H.M. Heemskerk

Associate professor, Head of Laboratory of experimental hematology

Leiden University Medical Center

NETHERLANDS

View details

Jennifer Picarsic

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Yanling Xiao

Assistant Professor

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jannie Borst

Research Interests

Explore related searches

Contact this professor

Articles (13)

CD4+ T-cell help delivery to monocyte-derived dendritic cells promotes effector differentiation of helper and cytotoxic T cells

CD27 costimulation supports metabolic fitness of CD4+ T cells by enhancing de novo nucleotide and protein synthesis

The importance of type I interferon in orchestrating the cytotoxic T-cell response to cancer

CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment

Trial watch

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4<sup>+</sup> regulatory T cells

TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4<sup>+</sup> T-Cell Metabolism

Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8<sup>+</sup> T cells.

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy

Flagellin/TLR5 Stimulate Myeloid Progenitors to Enter Lung Tissue and to Locally Differentiate Into Macrophages.

Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis

Collaborators (8)

Indu Khatri

Abhishek Garg

Elisa Matas-Rico

Stefan Naulaerts

Sandra Tuyaerts

Mirjam H.M. Heemskerk

Jennifer Picarsic

Yanling Xiao

Make your next move.